FDA Final Guidance: No Corrections And Removals Reports For Device Enhancements
This article was originally published in The Silver Sheet
Executive Summary
Online-Only Content >>> CDRH clarifies that Part 806 recall reports are not necessary for actual device enhancements that do not qualify as a correction or removal.
You may also be interested in...
Device Makers To FDA: Recall The Recalls Draft Guidance
The draft guidance is an attempt by FDA to reassure companies that they can make an enhancement to a marketed device without worrying that the action will be perceived as a recall. But the effort appears to have increased, rather than alleviated, industry anxieties.
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?
Thumbs Up: FDA Authorizes Weight Loss Suturing Systems From Apollo Endosurgery
People with obesity now have new tools to help them lose weight, thanks to the US agency’s de novo authorization.